Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2003
08/21/2003US20030158087 Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases
08/21/2003US20030157225 Food product and process
08/21/2003US20030157204 A plant extracts as immunomodulator treating autoimmune disorders, antiallergens treating hypersensitivity reactions; used as pharmaceuticals, cosmetics or dietary supplements
08/21/2003US20030157200 Use of oligosaccharides to stimulate beta-endorphin production
08/21/2003US20030157182 Pharmaceutical preparations and their manufacture
08/21/2003US20030157179 Use of magnetic particles
08/21/2003US20030157171 Chitosan-xanthane hydrogel including in its matrix a poorly water soluble drug which upon swelling of hydrogel in aqueous medium becomes at least partially solubilized and releasable therefrom
08/21/2003US20030157168 Comprises releasable opioid agonist (morphine); for prevention of abuse
08/21/2003US20030157167 Oxymorphone controlled release formulations
08/21/2003US20030157144 Desaturase genes and uses thereof
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157094 Prevention, therapy liver disorders, inflammatory bowel diseases, Crohn's disease; antiulcer agents; rheumatic diseases
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157030 Methods and compositions for therapeutic use of rna interference
08/21/2003CA2513198A1 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003CA2476618A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003CA2476553A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003CA2476454A1 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476162A1 Jnk inhibitor
08/21/2003CA2476113A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475770A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn.gamma.g(g)
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003CA2475439A1 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003CA2475338A1 Treatment of ophthalmic disorders using urea and urea derivatives
08/21/2003CA2474405A1 Medicament for the treatment of choroidal neovascularisation
08/21/2003CA2472822A1 Chemical compounds
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336620A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1336409A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders
08/20/2003EP1335924A2 Ethers of 7-desmethylrapamycin for use in immunosuppression
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/20/2003EP1335747A1 A composition of sodium channel blocking compound
08/20/2003EP1335718A1 6-methoxy-2-naphthylacetic acid prodrugs
08/20/2003EP1335716A1 Novel use of combined 5-ht 1a agonists and selective serotonin reuptake inhibitors
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0966295B1 Calcareous material
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003EP0821003B1 Peptides and remedy for autoimmune diseases comprising the same
08/20/2003EP0799040B1 Trisubstituted thioxanthines
08/20/2003EP0725772B1 Phytosphingosine-based ceramide i analogs
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437599A Tryasolyl tropane derivatives for therapy
08/20/2003CN1437591A Compounds and methods for modulation of estrogen receptors
08/20/2003CN1437588A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type l
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/20/2003CN1437472A Highly concentrated stable meloxicam solutions
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1436558A Plaster for treating pain and swelling
08/20/2003CN1436546A Prepn of women's inflammation diminishing film prepn
08/20/2003CN1118475C Cyclopeptide derivatives
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/20/2003CN1118458C Pyrimidinyl derivatives as interleukin inhibitors
08/20/2003CN1118287C Health-care medicine
08/20/2003CN1118285C Plaster for treating wind-cold arthritis with fixed pain caused by dampness
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608177 Mutation of serine replaced with cysteine; use as anti-HIV, anti-allergic or anti- inflammatory agents
08/19/2003US6608107 Administering gossypol; kits to treat patients
08/19/2003US6608105 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608084 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608072 Inhibiting production of soluble tumor necrosis factor or reducing inflammation
08/19/2003US6608070 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608044 Inhibition of TNF activity
08/19/2003US6608043 Administering complex of hyaluronic acid and zinc to patient having arthritic disease
08/19/2003US6608032 Medicinal compositions
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607726 Human tumor necrosis factor receptor TR10
08/19/2003CA2260337C Therapeutic agents
08/19/2003CA2099867C 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
08/19/2003CA2099061C Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
08/19/2003CA2085347C Novel cyclic aminophenylacetic acid derivative, production therof, and immune response modulator containing the same as active ingredient
1 ... 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 ... 1272